Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cancer Therapy and Testing
1.2 Key Market Segments
1.2.1 Cancer Therapy and Testing Segment by Type
1.2.2 Cancer Therapy and Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cancer Therapy and Testing Market Overview
2.1 Global Market Overview
2.1.1 Global Cancer Therapy and Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cancer Therapy and Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cancer Therapy and Testing Market Competitive Landscape
3.1 Global Cancer Therapy and Testing Sales by Manufacturers (2019-2024)
3.2 Global Cancer Therapy and Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Therapy and Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Therapy and Testing Sales Sites, Area Served, Product Type
3.6 Cancer Therapy and Testing Market Competitive Situation and Trends
3.6.1 Cancer Therapy and Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Therapy and Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cancer Therapy and Testing Industry Chain Analysis
4.1 Cancer Therapy and Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cancer Therapy and Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cancer Therapy and Testing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Therapy and Testing Sales Market Share by Type (2019-2024)
6.3 Global Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Therapy and Testing Price by Type (2019-2024)
7 Cancer Therapy and Testing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Therapy and Testing Market Sales by Application (2019-2024)
7.3 Global Cancer Therapy and Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Therapy and Testing Sales Growth Rate by Application (2019-2024)
8 Cancer Therapy and Testing Market Segmentation by Region
8.1 Global Cancer Therapy and Testing Sales by Region
8.1.1 Global Cancer Therapy and Testing Sales by Region
8.1.2 Global Cancer Therapy and Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Therapy and Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Therapy and Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Therapy and Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Therapy and Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Therapy and Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Invitae
9.1.1 Invitae Cancer Therapy and Testing Basic Information
9.1.2 Invitae Cancer Therapy and Testing Product Overview
9.1.3 Invitae Cancer Therapy and Testing Product Market Performance
9.1.4 Invitae Business Overview
9.1.5 Invitae Cancer Therapy and Testing SWOT Analysis
9.1.6 Invitae Recent Developments
9.2 Foundation Medicine
9.2.1 Foundation Medicine Cancer Therapy and Testing Basic Information
9.2.2 Foundation Medicine Cancer Therapy and Testing Product Overview
9.2.3 Foundation Medicine Cancer Therapy and Testing Product Market Performance
9.2.4 Foundation Medicine Business Overview
9.2.5 Foundation Medicine Cancer Therapy and Testing SWOT Analysis
9.2.6 Foundation Medicine Recent Developments
9.3 Guardant Health
9.3.1 Guardant Health Cancer Therapy and Testing Basic Information
9.3.2 Guardant Health Cancer Therapy and Testing Product Overview
9.3.3 Guardant Health Cancer Therapy and Testing Product Market Performance
9.3.4 Guardant Health Cancer Therapy and Testing SWOT Analysis
9.3.5 Guardant Health Business Overview
9.3.6 Guardant Health Recent Developments
9.4 Illumina
9.4.1 Illumina Cancer Therapy and Testing Basic Information
9.4.2 Illumina Cancer Therapy and Testing Product Overview
9.4.3 Illumina Cancer Therapy and Testing Product Market Performance
9.4.4 Illumina Business Overview
9.4.5 Illumina Recent Developments
9.5 Sysmex
9.5.1 Sysmex Cancer Therapy and Testing Basic Information
9.5.2 Sysmex Cancer Therapy and Testing Product Overview
9.5.3 Sysmex Cancer Therapy and Testing Product Market Performance
9.5.4 Sysmex Business Overview
9.5.5 Sysmex Recent Developments
9.6 Abingdon Health
9.6.1 Abingdon Health Cancer Therapy and Testing Basic Information
9.6.2 Abingdon Health Cancer Therapy and Testing Product Overview
9.6.3 Abingdon Health Cancer Therapy and Testing Product Market Performance
9.6.4 Abingdon Health Business Overview
9.6.5 Abingdon Health Recent Developments
9.7 Sophia
9.7.1 Sophia Cancer Therapy and Testing Basic Information
9.7.2 Sophia Cancer Therapy and Testing Product Overview
9.7.3 Sophia Cancer Therapy and Testing Product Market Performance
9.7.4 Sophia Business Overview
9.7.5 Sophia Recent Developments
9.8 NanoEntek
9.8.1 NanoEntek Cancer Therapy and Testing Basic Information
9.8.2 NanoEntek Cancer Therapy and Testing Product Overview
9.8.3 NanoEntek Cancer Therapy and Testing Product Market Performance
9.8.4 NanoEntek Business Overview
9.8.5 NanoEntek Recent Developments
9.9 BGI
9.9.1 BGI Cancer Therapy and Testing Basic Information
9.9.2 BGI Cancer Therapy and Testing Product Overview
9.9.3 BGI Cancer Therapy and Testing Product Market Performance
9.9.4 BGI Business Overview
9.9.5 BGI Recent Developments
9.10 Diagnosis
9.10.1 Diagnosis Cancer Therapy and Testing Basic Information
9.10.2 Diagnosis Cancer Therapy and Testing Product Overview
9.10.3 Diagnosis Cancer Therapy and Testing Product Market Performance
9.10.4 Diagnosis Business Overview
9.10.5 Diagnosis Recent Developments
9.11 Exact Sciences
9.11.1 Exact Sciences Cancer Therapy and Testing Basic Information
9.11.2 Exact Sciences Cancer Therapy and Testing Product Overview
9.11.3 Exact Sciences Cancer Therapy and Testing Product Market Performance
9.11.4 Exact Sciences Business Overview
9.11.5 Exact Sciences Recent Developments
9.12 AstraZeneca
9.12.1 AstraZeneca Cancer Therapy and Testing Basic Information
9.12.2 AstraZeneca Cancer Therapy and Testing Product Overview
9.12.3 AstraZeneca Cancer Therapy and Testing Product Market Performance
9.12.4 AstraZeneca Business Overview
9.12.5 AstraZeneca Recent Developments
9.13 Bayer AG
9.13.1 Bayer AG Cancer Therapy and Testing Basic Information
9.13.2 Bayer AG Cancer Therapy and Testing Product Overview
9.13.3 Bayer AG Cancer Therapy and Testing Product Market Performance
9.13.4 Bayer AG Business Overview
9.13.5 Bayer AG Recent Developments
9.14 Johnson and Johnson
9.14.1 Johnson and Johnson Cancer Therapy and Testing Basic Information
9.14.2 Johnson and Johnson Cancer Therapy and Testing Product Overview
9.14.3 Johnson and Johnson Cancer Therapy and Testing Product Market Performance
9.14.4 Johnson and Johnson Business Overview
9.14.5 Johnson and Johnson Recent Developments
9.15 Pfizer Inc.
9.15.1 Pfizer Inc. Cancer Therapy and Testing Basic Information
9.15.2 Pfizer Inc. Cancer Therapy and Testing Product Overview
9.15.3 Pfizer Inc. Cancer Therapy and Testing Product Market Performance
9.15.4 Pfizer Inc. Business Overview
9.15.5 Pfizer Inc. Recent Developments
10 Cancer Therapy and Testing Market Forecast by Region
10.1 Global Cancer Therapy and Testing Market Size Forecast
10.2 Global Cancer Therapy and Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Therapy and Testing Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Therapy and Testing Market Size Forecast by Region
10.2.4 South America Cancer Therapy and Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cancer Therapy and Testing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cancer Therapy and Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cancer Therapy and Testing by Type (2025-2030)
11.1.2 Global Cancer Therapy and Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cancer Therapy and Testing by Type (2025-2030)
11.2 Global Cancer Therapy and Testing Market Forecast by Application (2025-2030)
11.2.1 Global Cancer Therapy and Testing Sales (K Units) Forecast by Application
11.2.2 Global Cancer Therapy and Testing Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
